Outcomes of Intravitreal Dexamethasone Implant in Persistent Macular Edema Due to Retinal Vascular Diseases Intravitreal Dexamethasone Implant in Persistent Macular Edema

Journal Title: IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) - Year 2017, Vol 16, Issue 10

Abstract

Purpose: To evaluate the safety and efficacy of intravitreal Dexamethasone implant in patients with persistent macular edema due to retinal vascular diseases. Methods: This retrospective analysis was done after intravitreal injections of 0.7mg Dexamethasone implant Ozurdex in 22 eyes of 21 patients with persistent macular edema due to retinal vascular diseases either after at least one anti-VEGF intravitreal injection or photocoagulation from April 2015 to March 2016. Best corrected visual acuity (BCVA) was assessed through Snellen’s chart, and converted to logMar scale. Central macular thickness (CMT) was measured by Spectral-Domain Optical Coherence Tomography (SD-OCT). BCVA, Intraocular pressure (IOP) and CMT was noted at baseline (M0) and repeated after one month, three months, four months, and six months post injection. Results: The average thickness of the retina at baseline was 652𝜇m, the median BCVA was 0.8 logMAR, and corrected intraocular pressure was 12.8 mmHg. The maximum decrease in mean retinal thickness was observed at four weeks following the treatment and was 298𝜇m, and visual acuity improved by an average of four lines and was 0.4logMAR. No complications were observed during the follow-up. Conclusion: Intravitreal Dexamethasone implant appears effective in management of persistent macular edema due to retinal vascular disease with high safety level.

Authors and Affiliations

Arunava kundu, Debabrata datta, Sneha batra, Aniket ginodia, Preeyam biswas, Partha biswas

Keywords

Related Articles

Central Corneal Thickness in Adult Indians And its Effect on Glaucoma Progression: the Bundelkhand Region Glaucoma Study

Introduction : Central corneal thickness plays an important role in understanding the risk of glaucoma. Corneal thickness of less than 555µm provides false results of low intra ocular pressure, whereas, corneal thickness...

A Study Of Protein Oxidation And Alterations In The Saliva Of Oral Squamous Cell Carcinoma

Oral Squamous Cell Carcinoma (OSCC) of Oral Cavity is a common malignant tumor of themouth that typically affects elderly men and women. It is more aggressive than conventional squamous cell carcinoma affecting other bod...

Management of Chalazion: Surgical treatment versus Triamcinolone application- A Comparative Study

Chalazion or meibomian cyst is a chronic inflammatory lipid granuloma which is caused by the blockage of gland orificesandstagnatedsebaceoussecretionsinthe eyelid tarsus.Itcanaffectindividualsofallages and appears more f...

Does A Sealed Bracket Kit Give Sterility Check???

Introduction: Orthodontic brackets are classified as semicritical instruments. However, in orthodontic clinical practice, the use of brackets directly from non-sterile manufacturer’s packages is still a routine. In this...

Study Of Clinical Presentation And Management Of Patients Presenting With Fistula- In –Ano

Introduction: Fistula in ano is the common surgical problem prevalent worldwide and is also considered one of the commonest cause for a persistent sero-purulent discharge that irritates the skin in the neighborhood and c...

Download PDF file
  • EP ID EP244875
  • DOI 10.9790/0853-1610157882
  • Views 63
  • Downloads 0

How To Cite

Arunava kundu, Debabrata datta, Sneha batra, Aniket ginodia, Preeyam biswas, Partha biswas (2017). Outcomes of Intravitreal Dexamethasone Implant in Persistent Macular Edema Due to Retinal Vascular Diseases Intravitreal Dexamethasone Implant in Persistent Macular Edema. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS), 16(10), 78-82. https://europub.co.uk/articles/-A-244875